These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 6195902

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. General considerations of the interferon system.
    Baron S, Dianzani F.
    Tex Rep Biol Med; 1977; 35():1-10. PubMed ID: 616665
    [No Abstract] [Full Text] [Related]

  • 25. Therapeutic use of double-stranded RNAs in man.
    Borecký L, Lackovic V, Rovenský J.
    Tex Rep Biol Med; 1977; 41():575-81. PubMed ID: 6763367
    [Abstract] [Full Text] [Related]

  • 26. Interferon treatments: how to use an endogenous system as a therapeutic agent.
    Dianzani F.
    J Interferon Res; 1992 May; Spec No():109-18. PubMed ID: 1379281
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Interferon and interferon stimulation. New items in therapy of viral infections].
    Fanta D, Söltz-Szötz J.
    Hautarzt; 1974 Jul; 25(7):313-8. PubMed ID: 4369595
    [No Abstract] [Full Text] [Related]

  • 29. Interferon, an antiviral drug for use in man.
    Myers M, Galasso G.
    Tex Rep Biol Med; 1974 Jul; 41():543-8. PubMed ID: 6189221
    [No Abstract] [Full Text] [Related]

  • 30. Selective use of antiviral inhibitors: interferon, its inducers, and blockade of viral-reverse transcriptase.
    Carter WA, O'Malley JA, Horoszewicz JS, Huang J.
    Transplant Proc; 1975 Jun; 7(2):269-73. PubMed ID: 236611
    [No Abstract] [Full Text] [Related]

  • 31. A review of approaches to viral chemotherapy.
    Gordon M, Buchanan RL, Crenshaw RR, Kerridge KA, MacNintch JE, Siminoff P.
    J Med; 1981 Jun; 12(5):289-382. PubMed ID: 6171603
    [No Abstract] [Full Text] [Related]

  • 32. [Etiotropic therapy of viral neuroinfections].
    Lobzin VS, Sichko ZhV.
    Sov Med; 1980 Jun; (10):58-61. PubMed ID: 6160624
    [No Abstract] [Full Text] [Related]

  • 33. Interferon--present and future prospects.
    Richtsmeier WJ.
    Crit Rev Clin Lab Sci; 1984 Jun; 20(1):57-93. PubMed ID: 6202461
    [Abstract] [Full Text] [Related]

  • 34. [Interferon].
    Vargas Vorackova F, Mata Mendoza JM.
    Rev Invest Clin; 1981 Jun; 33(4):419-25. PubMed ID: 6173909
    [No Abstract] [Full Text] [Related]

  • 35. Mechanisms of interferon mediated anti-viral resistance.
    Clarke CJ, Trapani JA, Johnstone RW.
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):117-30. PubMed ID: 12476793
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Current problems on interferon research].
    Kishida T.
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):10-5. PubMed ID: 6198963
    [Abstract] [Full Text] [Related]

  • 39. Use of bacteriophage nucleic acid inducers of interferon in man.
    Borecký L.
    Tex Rep Biol Med; 1977 Jan; 35():535-40. PubMed ID: 358474
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.